PROFILE |
 |
"A spoonful of sugar" may now be obsolete. Biocompatibles International has developed its phosphorylcholine (PC) technology for use in health care and other markets. PC coatings reduce the possibility of a patient's bodily fluids having an adverse reaction to various medical devices, including contact lenses and coronary stents. Subsidiaries Biocompatibles Eyecare and Biocompatibles Hydron make the Proclear line of contact lenses, and are developing additional products that use PC technology for contact lens care and eye surgery. The company's Drug Delivery division focuses on research and development, with an emphasis on cardiovascular stents. The firm also has a marketing deal with Abbott Laboratories.
COMPETITION |
 |
Bio-Vascular, Inc. (BVAS)
Medtronic, Inc. (MDT)
SurModics, Inc. (SRDX)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 82.20
1-Yr. Sales Growth: 125.9%
Employees: 1,213
Revenue per employee: $67,765.87
KEY PEOPLE |
 |
Crispin Simon
CEO
Julian Steadman
CFO
CONTACT INFO |
 |
Frensham House, Farnham Business Park, Weydon Ln.
Farnham Surrey GU9 8QL, United Kingdom
Phone: 44-1252-732-732
Fax: 44-1252-732-777
Online: Web Site
|